Assessment with potential mapping of the cardiac protective effect of a drug. Example of trimetazidine

This publication has 13 references indexed in Scilit:

• Comparison of trimetazidine with nifedipine in effort angina: A double-blind, crossover study
  Cardiovascular Drugs and Therapy, 1990
• Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle of monocrotaline-treated rats
  Biochemical Pharmacology, 1988
• Trimetazidine, A Cellular Anti‐ischemic Agent
  Cardiovascular Drug Reviews, 1988
• Internal pH, Na+, and Ca2+ regulation by trimetazidine during cardiac cell acidosis
  Cardiovascular Drugs and Therapy, 1988
• Effect of trimetazidine on membrane damage induced by oxygen free radicals in human red cells.
  British Journal of Clinical Pharmacology, 1985
• Magnetic determination of the relationship between the S-T segment shift and the injury current produced by coronary artery occlusion.
  Circulation Research, 1975
• Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions
  Circulation, 1971
• Studies on the mechanism of ventricular activity. XII. Early changes in the RS-T segment and QRS complex following acute coronary artery occlusion: Experimental study and clinical applications
  American Heart Journal, 1954
• Electrocardiographic changes (local ventricular ischemia and injury) produced in the dog by temporary occlusion of a coronary artery, showing a new stage in the evolution of myocardial infarction
  American Heart Journal, 1944
• AN ELECTROCARDIOGRAPHIC SIGN OF CORONARY ARTERY OBSTRUCTION
  Archives of internal medicine (1960), 1920